knowledge -WSS

knowledge

author：explore 2025-09-28 01:38:21 - browse：3

Coronary medical stent -- health business coverage from STAT — Adobe

Coronary stenting is, by some measures, the most overused procedure in hospitals. The problem costs the health system millions and unnecessarily exposes patients to risks of blood clots, torn arteries, infections, and other life-threatening injuries.

In 2020, Medicare started paying physicians to place stents, balloons, and perform other procedures designed to open clogged coronary arteries outside of hospitals, in less expensive outpatient settings. It didn’t take long for private equity firms to catch on. They’ve been racing to buy up cardiology practices ever since, rolling them into bigger and bigger chains with an eye toward reselling them at a profit.

It’s similar to what happened with orthopedics and gastroenterology, two specialties that have become saturated with private equity money since more procedures went outpatient. Research in other specialties has shown that these financial investors tend to usher in more patients, ramp up surgeries, and jack up prices, effectively increasing spending even as government policies try to lower it. Now, experts say they fear the same thing could happen in cardiology, a field with a long track record of overuse.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： NIH trials fail to test meaningful long Covid therapies, experts say

knowledge

WSS

How to use technology to prevent future drug shortages

Man killed during FBI raid in connection with threats against Biden, other officials

The best solution to the drug shortages problem

Wegovy trial has doctors encouraged over new possibilities

Microbiome research is starting to find links to chronic diseases

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

leisure time

knowledge

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Friends ask where James Watson's attitudes about race came from

How one medical school became remarkably diverse

Biotech stock slump in 2023: awaiting the turnaround

Malaria cases in Florida and Texas: Here’s what you need to know

American woman, child freed after being kidnapped in Haiti last month

Drug repurposing or repositioning? The language matters

Lasker Awards 2023: Winners in biomedical research

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What to know about Virgin Galactic's 1st mission taking paying customers to space

focus

Wegovy’s successful heart trial raises vital question about weight loss

Second xenotransplant done with gene

Wegovy trial has doctors encouraged over new possibilities

EpiPen alternative approval delay highlights citizen petition issue

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

focus

knowledge

hotspot

explore